- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05113199
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
February 26, 2024 updated by: Deirdre R. Pachman, Mayo Clinic
Feasibility and Acceptability of Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the Virtual Dignity Therapy intervention to palliative care patients with advanced cancer.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is an investigator-initiated, single site Mayo Clinic Rochester prospective minimal risk pilot study to determine feasibility and acceptability of Virtual Dignity Therapy.
The Dignity Therapy intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness.
This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life.
This therapy consists of a total of 3 sessions, with each session 2-4 weeks apart, in which the investigator provides questions focused on life review.
The sessions are recorded and transcribed.
The interventionist will work with patients to edit the document and provide a final generativity document for patient to keep and give to loved ones.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic
-
Principal Investigator:
- Deirdre Pachman, MD
-
Contact:
- Melissa Felt
- Phone Number: 507-255-4162
- Email: Felt.Melissa@mayo.edu
-
Contact:
- Deirdre R. Pachman, MD
- Phone Number: (507) 293-9791
- Email: pachman.deirdre@mayo.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥18 years
- English fluency
- No diagnosed dementia
- Diagnosis of advanced cancer
- Expected prognosis > 6 months
- Provide informed consent
- Ability to complete questionnaire(s) by themselves or with assistance
Exclusion Criteria:
- Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
- Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
- Active delirium
- Participation in concurrent legacy offerings through the palliative care clinic
Inclusion Criteria for caregivers:
- Age ≥18 years
- English fluency
- Provide informed consent
- Supported patient through Dignity Therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Dignity Therapy
|
Virtual Dignity Therapy will be facilitated by a registered nurse or medical doctor trained in Dignity Therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility Number
Time Frame: 2 Years
|
Study feasibility will be measured by the number of participants who enrolled and finished the study.
|
2 Years
|
Acceptability
Time Frame: Week 8 (after 3rd intervention session)
|
Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns.
Positive responses indicate acceptability.
Results are reported as individual items.
|
Week 8 (after 3rd intervention session)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Deirdre Pachman, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 18, 2021
Primary Completion (Estimated)
October 31, 2024
Study Completion (Estimated)
October 31, 2025
Study Registration Dates
First Submitted
August 30, 2021
First Submitted That Met QC Criteria
October 28, 2021
First Posted (Actual)
November 9, 2021
Study Record Updates
Last Update Posted (Actual)
February 28, 2024
Last Update Submitted That Met QC Criteria
February 26, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancer
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University Health Network, TorontoUniversity of UlmRecruiting
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Canada, Argentina, Chile, Italy
-
Bristol-Myers SquibbTerminatedAdvanced CancerUnited States, Netherlands, Australia, Belgium, Canada, Italy, United Kingdom
Clinical Trials on Virtual Dignity Therapy
-
University of FloridaM.D. Anderson Cancer Center; National Cancer Institute (NCI); Northwestern University and other collaboratorsCompleted
-
European University of RomeRecruitingDeath | Psychological Distress | Emotional Stress | DignityItaly
-
Azienda Unità Sanitaria Locale Reggio EmiliaCompletedAdvanced Cancer | DignityItaly
-
Memorial Sloan Kettering Cancer CenterEnrolling by invitationEnd of LifeUnited States
-
University of ZurichWaid City Hospital, ZurichCompletedDepressive Disorder | Dementia, MildSwitzerland
-
Mayo ClinicCompletedPancreatic Cancer | Non-Small-Cell Lung CancerUnited States
-
University of ZurichSwiss Cancer LeagueCompleted
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedStage IV Colorectal CancerUnited States
-
University of ManitobaCanadian Institutes of Health Research (CIHR)CompletedPalliative Care | Family | End of Life CareCanada
-
Penn State UniversityActive, not recruitingDementia | Nurse's Role | Nursing Homes | Staff AttitudeUnited States